We are live on ! Find out more
Eversept Partners

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
+$31.2M
Cap. Flow
+$169M
Cap. Flow %
8.75%
Top 10 Hldgs %
45.68%
Holding
151
New
31
Increased
40
Reduced
42
Closed
31
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.1 years

Top Buys

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$104M
2
EHC icon
Encompass Health
EHC
+$86.2M
3
CTRE icon
CareTrust REIT
CTRE
+$42.1M
4
UNH icon
UnitedHealth
UNH
+$19M
5
INSM icon
Insmed
INSM
+$18.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.9M
2
NTRA icon
Natera
NTRA
+$44.5M
3
DOC icon
Healthpeak Properties
DOC
+$32.5M
4
AVTR icon
Avantor
AVTR
+$23.3M
5
QGEN icon
Qiagen
QGEN
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.53%
2 Real Estate 5.59%
3 Miscellaneous 4.84%
4 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DAWN icon
126
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-183,902
Closed -$3.94M –
DHC icon
127
Diversified Healthcare Trust
DHC
$1.9B
– –
-151,283
Closed -$1M –
DOC icon
128
Healthpeak Properties
DOC
$13.3B
– –
-1,981,070
Closed -$32.5M –
EHAB icon
129
DELISTED
Enhabit
EHAB
– –
-227,451
Closed -$3.2M –
ESPR icon
130
DELISTED
Esperion Therapeutics
ESPR
– –
-1,735,963
Closed -$4.76M –
HQY icon
131
HealthEquity
HQY
$8.6B
– –
-51,614
Closed -$4.31M –
HYG icon
132
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17B
– –
-180,000
Closed -$14.3M –
ICLR icon
133
Icon
ICLR
$14.3B
– –
-68,688
Closed -$7.6M –
IMCR icon
134
Immunocore
IMCR
$1.6B
– –
-39,238
Closed -$1.18M –
INMD icon
135
InMode
INMD
$804M
– –
-67,744
Closed -$927K –
IWM icon
136
PUT
iShares Russell 2000 ETF
IWM
$79.1B
– –
-40,000
Closed -$9.9M –
KPTI icon
137
CALL
Karyopharm Therapeutics
KPTI
$11.7M
– –
-23,800
Closed -$133K –
MDGL icon
138
Madrigal Pharmaceuticals
MDGL
$10B
– –
-10,000
Closed -$5.23M –
NVCR icon
139
NovoCure
NVCR
$1.71B
– –
-134,917
Closed -$1.47M –
PASG icon
140
Passage Bio
PASG
$10.8M
– –
-131,581
Closed -$1.03M –
PRAX icon
141
PUT
Praxis Precision Medicines
PRAX
$7.06B
– –
-14,800
Closed -$4.77M –
QGEN icon
142
Qiagen
QGEN
$10.4B
– –
-545,330
Closed -$20.3M –
REPL icon
143
CALL
Replimune Group
REPL
$1.08B
– –
-52,000
Closed -$398K –
SPY icon
144
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
– –
-107,000
Closed -$69.6M –
STRO icon
145
Sutro Biopharma
STRO
$155M
– –
-73,161
Closed -$1.82M –
TLT icon
146
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$48.9B
– –
-428,800
Closed -$37.2M –
TYRA icon
147
Tyra Biosciences
TYRA
$1.41B
– –
-27,055
Closed -$1.04M –
UNH icon
148
CALL
UnitedHealth
UNH
$375B
– –
-40,000
Closed -$10.8M –
VRTX icon
149
CALL
Vertex Pharmaceuticals
VRTX
$133B
– –
-90,000
Closed -$40.2M –
XLE icon
150
CALL
State Street Energy Select Sector SPDR ETF
XLE
$45.4B
– –
-50,000
Closed -$3.06M –
3 4 5
6
7

Similar funds

Segment Wealth Management
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
Regal Investment Advisors
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
Standard Investments
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
Sourcerock Group
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
Distillate Capital Partners
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
Sofinnova Investments
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MHR Fund Management
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FAS Wealth Partners
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Eversept Partners held 151 positions worth $1.93B, up 1.6% from $1.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Eversept Partners deployed $169M of net new capital in Q2 2026, opening 31 new positions and adding to 40 existing holdings. Its largest new stake was CareTrust REIT: 1,072,015 shares worth $43.3M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 74% a quarter earlier, followed by Real Estate and Miscellaneous.

On the sell side, the largest reduction was GSK, an estimated $68.9M trimmed.

  • Eversept Partners's largest Q2 2026 buy was CareTrust REIT: 1,072,015 shares worth $43.3M.
  • Eversept Partners added most to The Ensign Group in Q2 2026, an estimated $104M increase.
  • Eversept Partners's biggest Q2 2026 reduction was GSK, cutting an estimated $68.9M.
  • Eversept Partners fully exited Healthpeak Properties in Q2 2026, selling an estimated $32.5M.
  • Eversept Partners's ten largest holdings make up 46% of its $1.93B portfolio in Q2 2026.
  • Eversept Partners opened 31 new positions and closed 31 in Q2 2026.
  • Eversept Partners's portfolio value rose 1.6% quarter-over-quarter to $1.93B.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.